BP and lipid lowering drugs fail to show cognitive benefit in older adults

Long-term cholesterol and blood pressure-lowering drugs have failed to show a cognitive benefit in older adults in a sub-study of the HOPE-3 trial but findings suggest there may be some benefit for those at highest cardiovascular risk. Lowering blood pressure using candesartan plus hydrochlorothiazide or rosuvastatin to lower cholesterol, or a combination of the two, ...

Already a member?

Login to keep reading.

© 2021 the limbic